GGrantIndex
Sort

141,003 grants matching cytokine

Regulation Of Lung Immunity By Antibody Glycosylation

$860,851
Taia Wang · Stanford University · R01 · FY2025 · AI

Effects of experimentally-induced reductions in alcohol consumption on brain cognitive, and clinical outcomes and motivation for changing drinking in older persons with HIV infection

$860,831
Robert L Cook · University Of Florida · U01 · FY2019 · AA

Role of p38 MAPK activation in AIDS pathogenesis

$860,742
Anna Aldovini · Boston Children'S Hospital · R01 · FY2016 · AI

Pathogenesis of Burkholderia mallei and pseudomallei

$860,717
Frank Gherardini · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Role of p38 MAPK activation in AIDS pathogenesis

$860,699
Anna Aldovini · Boston Children'S Hospital · R01 · FY2017 · AI

CD4_T-cell_Immunity_in_the_Lung

$860,539
Jay K Kolls · Tulane University Of Louisiana · R35 · FY2018 · HL

A Combination Trial of Copaxone Plus Estriol in RRMS

$860,439
Rhonda R Voskuhl · University Of California Los Angeles · R01 · FY2009 · NS

Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling

$860,375
Jason S Debley · Seattle Children'S Hospital · R01 · FY2024 · AI

Bispecific Antibody Therapeutics for Neuroblastoma and Diffuse Midline Glioma

$860,018
James M Olson · Seattle Children'S Hospital · U01 · FY2023 · CA

PRECISION COMBINATORIAL IMMUNOTHERAPEUTIC TARGETING OF CYTOKINE RECEPTOR KINASE SIGNALING IN CRLF2-REARRANGED ALL

$859,992
The Children'S Hospital Of Philadelphia · · FY2019 · Defense Health Agency

Prostaglandin E2-Dependent Control of a Mast Cell IL-33/ST2 Pathway in Asthma

$859,874
Joshua A Boyce · Brigham And Women'S Hospital · R01 · FY2025 · AI

Prostaglandin E2-Dependent Control of a Mast Cell IL-33/ST2 Pathway in Asthma

$859,874
Joshua A Boyce · Brigham And Women'S Hospital · R01 · FY2024 · AI

The regulatory role of natural progesterone in barrier immunity

$859,848
Florian Hladik · University Of Washington · R01 · FY2024 · AI

NF-kappaB in pathogenesis and therapy of head and neck cancer

$859,665
Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2014 · DC

BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma

$859,480
Damian J. Green · Fred Hutchinson Cancer Research Center · P01 · FY2021 · CA

Biomechanics and Inflammation in Osteoarthritis

$859,454
Farshid Guilak · Duke University · P01 · FY2010 · AR

Combination Therapy with Semaglutide and Anti-Amyloid Antibodies for Alzheimers Disease

$859,410
Cynthia A Lemere · Brigham And Women'S Hospital · R01 · FY2024 · AG

The regulatory role of natural progesterone in barrier immunity

$859,361
Florian Hladik · University Of Washington · R01 · FY2025 · AI

Prediction of Alcohol Use Disorder and PTSD After Trauma in Adolescents

$859,337
Charles B Nemeroff · University Of Texas At Austin · R01 · FY2024 · AA

Relationships between immunosenescence, brain aging biomarkers, and cognition across nonhuman primate species of differing lifespans

$859,240
Michele M Mulholland · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · AG

Prostaglandin E2-Dependent Control of a Mast Cell IL-33/ST2 Pathway in Asthma

$859,235
Joshua A Boyce · Brigham And Women'S Hospital · R01 · FY2023 · AI

PROTECTIVE MECHANISMS WITH ATTENUATED LENTIVIRAL VACCINE

$859,182
University Of California Davis · R01 · FY2001 · AI

Translating cellular immunotherapies for autoimmunity to canine clinical trials

$859,159
Aimee S Payne · University Of Pennsylvania · R01 · FY2020 · AR

Discovery of Drugs that Modulate Neuroinflammation for the treatment of Alzheimer's Disease

$859,080
Kevin Hodgetts · Brigham And Women'S Hospital · U01 · FY2024 · AG

Treatment of Autoimmune Disease by Costimulatory Signal*

$859,049
Brigham And Women'S Hospital · U19 · FY2004 · AI